ExozymesEXOZ
13F holders, Q3 2025 (September 30)6holders −3
0new positions
3sold out
$14.69avg. 13F price*
At the end of Q3 2025, 6 institutions reported holding Exozymes Inc. (EXOZ) in their 13F filings, down 3 from Q2 2025. 0 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($383K), Geode Capital Management, LLC ($340K) and BlackRock, Inc. ($72K).
- Company
- Exozymes Inc.
- CUSIP
- 461874109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $197K |
All 13F filers, Q2 2025 → Q3 2025: 5,435 shares bought and 20,894 shares sold, net −15,459 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Vanguard Group Inc. | 0.00% | Add +12.2% | 25,981 | $383K |
| Geode Capital Management, LLC | 0.00% | Add +12.0% | 23,063 | $340K |
| BlackRock, Inc. | 0.00% | Add +3.0% | 4,985 | $72K |
| UBS Group AG | 0.00% | Reduce -7.8% | 4,621 | $67K |
| Morgan Stanley | 0.00% | No change | 1,250 | $18K |
| Bank of America Corp. | 0.00% | Reduce -36.1% | 23 | $332 |
"% of holder's portfolio" is EXOZ's weight in each manager's 13F, not the share of Exozymes Inc. the manager owns.